HT
MRTX

HAP Trading’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

HAP Trading’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-75,200
Closed -$139K – 1765
2022
Q4 		$139K Buy
+75,200
New +$4.87M 0.01% 530
2022
Q3 		– Sell
-18,300
Closed -$120K – 2177
2022
Q2 		$120K Buy
+18,300
New +$1.16M 0.01% 844
2021
Q2 		– Sell
-27,500
Closed -$101K – 2712
2021
Q1 		$101K Sell
27,500
-142,200
-84% -$28.2M 0.01% 954
2020
Q4 		$377K Buy
+169,700
New +$36.7M 0.01% 727
2020
Q3 		– Sell
-50,100
Closed -$217K – 1989
2020
Q2 		$217K Sell
50,100
-40,600
-45% -$3.94M 0.01% 663
2020
Q1 		$174K Buy
90,700
+75,300
+489% +$6.75M 0.01% 567
2019
Q4 		$160K Sell
15,400
-118,200
-88% -$11.4M 0.01% 487
2019
Q3 		$397K Sell
133,600
-39,100
-23% -$3.67M 0.03% 353
2019
Q2 		$852K Buy
172,700
+132,300
+327% +$10.3M 0.07% 244
2019
Q1 		$50K Buy
+40,400
New +$2.75M ﹤0.01% 672

Other funds holding MRTX

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

HAP Trading's MRTX Position: Q1 2023 in Review

HAP Trading sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2023, closing a stake of 13,554 shares — an estimated $614K sold.

HAP Trading first reported a position in MRTX in Q1 2019 and held it in 3 quarters. The position peaked at $4.53M in Q4 2019. 221 funds tracked by Wall St. Rank hold MRTX as of Q1 2023.

  • HAP Trading reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • HAP Trading sold 13,554 Mirati Therapeutics, Inc. Common Stock shares in Q1 2023, an estimated $614K.
  • HAP Trading first reported a position in Mirati Therapeutics, Inc. Common Stock in Q1 2019 and held it in 3 quarters.
  • HAP Trading's Mirati Therapeutics, Inc. Common Stock position peaked at $4.53M in Q4 2019.
  • 221 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2023.

Based on HAP Trading's 13F filing for Q1 2023, filed 12 May 2023.